Editorial Board
Davide Barreca is an Associate Professor of biochemistry at the University of Messina. He is specialized in enzyme modulation by natural compounds, inhibition of protein aggregation and activation of signal apoptotic cascade. Most of his research projects concentrate on separation and identification of unknown flavonoids, structural-activity elucidation, and biochemical analysis of their health promoting or cytotoxicity properties on cells culture. He is author of over 90 papers in peer-reviewed journals, 30 chapters in books, and 70 conference proceedings and reviewer of over 40 international scientific journals.
Dr. M. Iqbal Choudhary is a Distinguished National Professor of Organic Chemistry and Director at International Center for Chemical and Biological Sciences (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research). He is among the most prominent scientists of Pakistan, recognized for his original contributions in the fields of natural products and bioorganic chemistry. He has written and edited 50 books, most of which have been published in USA and Europe. He is also the author of over 900 research papers and chapters in top international science journals of the West, as well as 43 US patents. The cumulative impact factor of his publications is over 1,750. This is by far the largest number of quality publications from any scientist in Pakistan. He has been among the most cited scientists of Pakistan in last five years with citations exceeding 11,000 (h-Index: 41).
Dr. Chen received his B.Sc in Chemistry from Sichuan University, China and Ph.D. in Pharmaceutical Chemistry from Nagasaki University, Japan. Dr. Chen even worked as a CREST postdoctoral researcher at Nara Institute of Science and Technology, Japan, as an associate professor at Sun Yat-sen University, China and as a research scientist at Lehigh University, Pennsylvania, USA. Currently Dr. Chen is a full professor at Southern Medical University, China. He has published more than 90 peer-reviewed papers. Dr. Chen is also currently the Associate Editor of Mini-Reviews in Medicinal Chemistry (MRMC), published by Bentham Science Publishers.
Dr. Lee has worked on numerous drug discovery projects related to traditional Chinese medicine, contributing significantly to the development of alternative therapies for substance abuse and for osteoarthritis. He is the principal investigator on “Alternative Therapies for Alcohol and Drug Abuse,” a program project grant funded by the National Institutes of Health. Dr. Lee and his colleagues at McLean Hospital and Harvard Medical School are also looking into natural remedies for diabetes, depression, autism, schizophrenia, and Alzheimer’s disease. Dr. Lee received an institutional development award in 1985, has published 110 papers and holds 15 US and international patents.
Jian-Qiang Liu received Ph.D from Northwest University. He completed his postdoc at Tsinghua University (with Prof. Lin Mei, 2015-2016) and has been working as a full professor at Guangdong Medical University. His research interests include multifunctional metal-organic framework nanomaterials, and stimuli-responsive (bio) polymers. He has published more than 50 papers. H-index = 22. He has been appointed as an editorial board member of several journals, such as: Interdisciplinary Journal of Chemistry; and EC Pharmacology and Toxicology etc.
Prof. Hwu obtained a doctorate (Ph.D.) in Chemistry from Stanford University, California, USA. He has been a Distinguished Chair Professor of National Tsing Hua University, Taiwan and served as the President of Asian Federation for Medicinal Chemistry in 2012 and 2013. He has published more than 200 scientific publications and is a named inventor of 49 issued patents internationally. Professor Hwu has been Fellow of TWAS, IUPAC, and The Royal Society of Chemistry, UK.
Professor Husbands joined the Department of Pharmacy and Pharmacology at the University of Bath in 2000, was made a Fellow of the Royal Society of Chemistry in 2010 and then Professor in 2012. He has been Head of the Medicinal Chemistry group within the Department since 2013. Prof Husbands’ main research interests relate to neuropsychological diseases, in particular drug abuse, but also including depression and anxiety. Recent research interests have focussed on the development and therapeutic potential of ‘selectively promiscuous’ ligands and has been driven by the understanding that CNS disorders are rarely simple, requiring complex solutions. Prof Husbands has published >100 peer-reviewed scientific papers, mostly on CNS active molecules.
Nikos Tagmatarchis is the Deputy Director in the Theoretical and Physical Chemistry Institute, at the National Hellenic Research Foundation, Athens, Greece. He has studied chemistry and received his PhD from the Chemistry Department, University of Crete, Greece (1997). Dr. Tagmatarchis’s accomplishments are reflected in over 180 scientific peer- reviewed research articles, while his work has been cited more than 8200 times, associated with an h-index of 37. He has been recipient of the European Young Investigator Award (2004), Visiting Professor at the Chinese Academy of Sciences (2011-2012) and Invited Fellow by the Japan Society for the Promotion of Science in Japan (2013- 2014).
Prof. Anna Artese received the bachelor degree in Pharmacy in 2004 from University "Magna Græcia" of Catanzaro. In 2005, she specialized in Software Development and in 2008 she received her PhD in Medical Microbiology and Immunology at University of Rome "Tor Vergata". Currently, she is an Associate Professor of Medicinal Chemistry at the University "Magna Græcia" of Catanzaro. Prof. Artese serves as reviewer and guest editor for several scientific journals in the field of drug design and medicinal chemistry. She has published 76 articles on SCI-indexed journals related to medicinal chemistry. Her scientific expertise is related to the application of new computational algorithms to analyze the drug receptor intermolecular interactions and to design anticancer, antiviral and analgesic agents.
Prof. Busardò obtained in 2009 his Degree with honor in Medicine and Surgery at the University of Palermo (Italy), winning the Prize for the Best Thesis. In 2014, he received a Diploma in Forensic and Medical Sciences from The Worshipful Society of Apothecaries of London. In 2015, he specialized in Forensic Medicine at Sapienza University of Rome, Italy. In 2015, he obtained MSc in Forensic Toxicology from the University of Glasgow, Scotland, UK. In 2017, he obtained a PhD in Legal Medicine and Forensic Sciences from the Sapienza University of Rome, Italy. Since March 2018, he is an Adjunct Professor of Forensic Science and Toxicology and lead forensic toxicologist at Sapienza University of Rome, Italy. He then became Associate Professor of Forensic Science and Toxicology at University "Politecnica delle Marche" of Ancona, Italy in 2018. He is an expert in the field of legal medicine, drug addiction, doping problems and drugs and crimes. He is the author of more than 200 peer reviewed publications on forensic toxicology and legal medicine, with an H index of 38.
Dr. Chattopadhyay, Scientist-G & Director at ICMR-NITM Belagavi India, is a leading Ethnomedicine and Virus specialist, working on difficult-to-treat diseases. He has established personal contact with diverse tribes, and validated their age-old-tradition for translating traditions into innovation. He has 8-patents, 4-leads, 4-Books, 55 popular and 137 research- articles. His h-Index is 33 and have 3541 citations. He is the editor, editorial member and reviewer of several peer-reviewed Journals of global repute, and served as PhD Guide, visiting Faculty, examiner and member of Research Advisory Board and Board of Studies of Universities. He is the recipient of several awards, Fellow of BSAC (UK), Member of DST-SERB Expert Committees, and produced 15 PhDs.
Maria Luisa graduated from the University of Calabria, Italy in 2000, with a Laurea in Pharmacy. In 2005, she received her Ph.D. in Methodologies for Development of Molecules of Pharmacological Interest at the University of Calabria. She is a researcher of Organic Chemistry at the University of Calabria since 2006. Her research interests focus on the synthesis and characterization of molecules with potential biological activity, in particular peptides. In this field, her chemical research investigates the application of the principles of green chemistry for the development of sustainable chemical processes to afford biologically active compounds.
Dr. Marcello Iriti did PhD and he is a Professor of Plant Biology and Pathology at the Department of Biomedical, Surgical and Dental Sciences, Milan State University. He has been studying nutraceuticals, functional foods, phytotherapeutics and essential oils relevant for human and animal health, focusing on their preclinical (in vitro/in vivo) and in human pharmacological activities. He has been investigating the health-promoting effects of traditional Mediterranean diet as well as the ethnopharmacology of herbal remedies of traditional healing systems. He is a member of the World Academy of Sciences and Asian Council of Science Editors. Founding Member of the Italian Society of Environmental Medicine. Member of the Working Group 'Pharmacognosy, Phytotherapy and Nutraceuticals' of the Italian Pharmacological Society. His main Patent: 'Compositions Comprising Rutin Useful for the Treatment of Tumors Resistant to chemotherapy'. He is an Associate Editor-in-Chief of International Journal of Molecular Sciences (IF 6.2) and a Section Editor of Medicine (IF 1.8), Associate Editor of Frontiers in Nutrition (IF 6.5), Cellular and Molecular Biology (IF 1.7) and EBM of a number of journals.
Prof. Jianhua Liu obtained his PhD in inorganic chemistry from Chemistry College of Jilin University. He worked as a visiting scholar in Ulm University in Germany (2019). He currently works as chief physician and Professor, Vice Director in the Department of Radiology, the Second Hospital of Jilin University, China. Prof. Liu has authored more than 60 scientific papers in the medicinal chemistry field (h-index: 27), including ACS Nano, Biomaterials, Small, Theranostics, ACS Appl Mater Interfaces, Nanoscale, Curr Top Med Chem, Curr Med Imaging Rev etc. His research mainly focused on synthesis of nanoparticles for medical imaging and therapy.
Prof. Giovanna Poce obtained her PhD in Pharmaceutical Sciences from Sapienza University, Italy, in 2008. She has been a Visiting Scientist in the Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, United States. She was appointed as Associate Professor in the Department of Chemistry and Technologies of Drug, Sapienza University of Rome, in 2022. Her main research interests are on developing small molecules as antimicrobials with a special focus on malaria transmission-blocking agents and antitubercular compounds.
Virginia Spanò graduated with a degree in Pharmaceutical Chemistry and Technology (magna cum laude) from the University of Palermo (Italy) in 2005. She received her Ph.D. in Medicinal Chemistry in 2009. In the same year, she received a postdoctoral fellowship at the Faculty of Pharmacy of Palermo. At present, she is an Associate Professor at the Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) of University of Palermo. Her current research interests include synthesis, identification, and biological evaluation of nitrogen heterocyclic compounds as antitumor agents.
Tiziano Tuccinardi is Associate Professor of Medicinal Chemistry at the Department of Pharmacy of the University of Pisa. Since July 2016 he is also Adjunct Associate Professor at the Department of Biology, Temple University’s College of Science and Technology, Philadelphia, PA, USA. He has published more than 130 papers, five patents and he is a scientific advisory board member of the Bio Future Medicine (BFM) start-up. His research interests include drug and lead discovery, with a focus on computer-assisted approaches and medicinal chemistry, including synthesis of small molecules, virtual and biomolecular screening.
Wenwen Zhang obtained his MD, Ph.D degree in Clinical Medicine at Nanjing University in 2017. He is now a clinician in the Department of Oncology, Nanjing First Hospital, Nanjing, China. He has published 40 papers focused on breast cancer translational research and mechanisms of metastasis of breast cancer, especially triple-negative breast cancer (TNBC).
Dr Ben got his PhD in Pharmaceutical Sciences from the University of Padova (Italy) then he moved to the University of Camerino (Italy) where he is currently an Associate Professor of Medicinal Chemistry. His research work is to design and optimize bioactive compounds with molecular modelling tools. His studies are focused mainly to membrane proteins belonging to the GPCR (Purinergic P1 Receptors and others) and ion channel (Purinergic P2X Receptors) protein families.
Dr. Kalász earned his PhD, and he was awarded the title of doctor of chemical sciences, and medical habilitation in pharmacology at Semmelweis University. Dr. Kalász is employed in the Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest. He was also working in Yale University (New Haven, CT, USA), University of Cincinnati, Cincinnati (Cincinnati, OH, USA) and United Arab Emirates University (Al Ain, UAE). He has several decades of experience in the isolation of natural products, identification of drug binding sites and in studies on pharmacokinetics and drug metabolism.
Professor Abell graduated from the University of Adelaide with BSc(Hon) and PhD and then undertook a postdoctoral fellowship at the University of Cambridge. He held a professorship at the University of Canterbury before returning to the University of Adelaide in 2007, where he is currently Professor of Chemistry and node director of the ARC Centre of Excellence for Nanoscale Biophotonics. Prof. Abell co-founded Calpain Therapeutics to develop macrocyclic protease inhibitors as a potential treatment for cataract and other conditions. Past Head of School of Chemistry and Physics at Adelaide and recipient of Royal Australian Chemical Institute Adrien Albert Prize and the Alexander R. Matzuk Prize and Lecture in Drug Discovery (Baylor College of Medicine, Houston).
Dr. Kelong Ai obtained his Ph.D from Jilin University in 2018. He is working as a full professor in Central South University. He is engaged in research on cardio-cerebrovascular repair and cancer treatment and diagnosis. So far, he has published more than 52 SCI academic peer reviewed papers, his articles have been cited more than 8400 times.
Dr. Feifei An graduated from Huaqiao University in 2008, and then received his Ph.D degree from Chinese Academy of Sciences in 2013. After one-year research in National Center of Nanoscience and Nanotechnology, Dr. An joined Cornell University as a postdoctoral associate. Dr. An joined Xi’an Jiaotong University as an associate professor in 2018. Dr. An has published 30 papers in SCI journals and these papers have been cited over 600 times. Dr. An’s research interest is medicinal chemistry and nanomedicine. His group is composed of organic chemists and biologists.
Dr Aremu received his PhD (Botany) from the University of KwaZulu-Natal, South Africa in 2012. He is currently a Senior Lecturer/Researcher at the Centre for Indigenous Knowledge Systems, North West University, South Africa. He is a member of the South African Young Academy of Science (SAYAS) and Fellow of the African Science Leader Programme (ASLP). Dr Aremu research focuses on the documentation, bioactivity testing, chemical characterization and safety evaluation of African floras especially those with medicinal, horticultural and nutritional potential. Since 2008, he has authored/co-authored 95 peer-reviewed publications in ISI-rated journals (1780 citations and H-index of 22). Dr Aremu is also serving as an editorial board member for several international journals of repute and funding bodies.
Dr. Mahmood Bahmani. graduated from in Doctor Veterinary Medicine (D.V.M) and did Ph.D. in Pharmaceutical Sciences. He is a member of the Biotechnology and Medicinal Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran, his h-Index is 39 from Scopus.
Professor Gil Bar-Sela is Deputy Director of the Division of Oncology and Head of the Palliative and Supportive Oncology Unit at Rambam Health Care Campus, Haifa, Israel. Professor Bar-Sela is also an Associate Professor at the Technion’s Ruth & Bruce Rapapport Faculty of Medicine. To date he has published more than 100 papers in medical journals and books. Professor Bar-Sela is currently a member of the Advisory Committee of the Israel Cancer Association on Palliative Care and the committee for professional guidance. He is also a member of the "Survivorship Committee" of the National Council for the Prevention, Diagnosis & Treatment of Cancer.
Dr. Younis Baqi is an Assistant Professor of Medicinal Chemistry at Sultan Qaboos University (SQU), Oman and presently is a coordinator of Applied Chemistry. His early training was in natural products chemistry at the University of Jordan (M.Sc. 2003) and pharmaceutical chemistry at Universität Bonn (Ph.D., 2008). After a research stay at the laboratory of Prof. E.J. Corey, Harvard University; MA, USA, he was appointed as a group leader within ERA- NET fellowship (2009–2011). Since 2012, he is holding the position of Assistant Professor of Chemistry at SQU, Oman.
Dr. Bharate obtained B.Pharm from the University of Pune, and then he received M.S.Pharm and PhD degree from NIPER-Mohali (India). He has industrial experience (Dr. Reddy's Lab, Piramal Life Sciences) and has done postdoctoral studies at University of Montana (USA) in the area of neuroscience. Presently, he is working as a Principal Scientist in the Medicinal Chemistry Division of CSIR-Indian Institute of Integrative Medicine. His current research interests are in the field of medicinal chemistry of natural products to discover new therapeutics for the treatment of Alzheimer’s disease and cancer. He is a recipient of several incentive awards, and three young scientist awards (NASI, CSIR, OPPI). He is a reviewer for various international journals. He has published 136 papers and has 17 patents to his credit.
Dr. Bobryshev obtained a doctorate (Ph.D.) from the Leningrad state University, Leningrad, in 1978. Currently Dr. Bobryshev is a Leading Scientist of Institute of Pathology and Pathophysiology, Moscow, and an Adjunct Associate Professor in the University of Western Sydney,Australia. He is author or co-author of more than 200 scientific publications.
Dr. Monica Butnariu completed her Ph.D. in 2005 from Banat University, Romania. In 2013, she became a habilitated doctor from Cluj-Napoca University, Romania. She is a professor at the University of Agricultural Sciences and Veterinary Medicine of Banat "King Mihai I of Romania" in Timisoara, Romania (Chemistry & Biochemistry Discipline). Dr. Butnariu has numerous articles published in the Science Citation Index (SCI), International Scientific Indexing (ISI), Web of Science Core Collection, and Clarivate Analytics that have been cited over 1200 times, and her publication H-index is 32 (Citation Metrics WoS). She has been serving as an editorial board member of some reputed journals and is also involved in peer review activities. So far, she has written several books and book chapters on different areas of chemistry. In addition, she has received the Romanian Academy Award for chapter ‘Chemical Composition of Vegetables and their Products’ in the Handbook of Food Chemistry (http://www.acad.ro/premiileAR/liste/2014.pdf). Currently, she is the head of CONEM Romania Biotechnology and Environmental Sciences Group and also the National Correspondent of the International Association for Plant Biotechnology.
Dr. Simone Carradori, after completing graduation in “Drug Chemistry and Technology”, obtained his PhD in “Pharmaceutical Sciences” at the University of Rome "La Sapienza" (Italy). He collaborates with several departments abroad. Currently, he is assistant professor at the Department of Pharmacy of “G. d’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is mainly focused on the synthesis and characterization of heterocyclic derivatives as well as extraction of natural compounds with potential biological activity, and is documented from several papers in international peer-reviewed journals, one European patent and participations in numerous conferences.
Alessia Carocci graduated in Chemistry and Pharmaceutical Technology, summa cum laude, at the University of Bari in 1992. She received a Ph.D. in Medicinal Chemistry from the same University, in 1998. A post-doctoral position and a research grant in Medicinal Chemistry were held between 1999 and 2001. Since 2002, she was a researcher and since 2017 she is an associate professor of medicinal chemistry at the department of Pharmacy-Drug Sciences of the University of Bari. She is a member of the Ph.D. school and the Italian Chemical Society. She is author of more than 65 papers and reviews in high IF peer-reviewed international journals and 6 chapters in books. She regularly serves as a reviewer for several international scientific journals. Her research interests include the synthesis of biologically active compounds in the field of antimitotic, antiarrhythmic, antitumor, antibacterial and melatonergic drugs.
Dr. Colotti is a Ph.D. in Biochemistry, University Sapienza, Rome. He is a Research Scientist, Group Leader at the Institute of Molecular Biology and Pathology, Italian National Research Council. He is the author of about 60 publications in peer-reviewed international journals, member of the editorial board of several journals, co-founder and member of the Foresight Group CNR and of qPMO (Quality and Project Management OpenLab) CNR. His research interest focus on: structure and function of proteins involved in human diseases; drug delivery, drug targeting; drug discovery; calcium signaling in cancer and neurodegenerative diseases; and mitochondrial tRNAs.
Dr. Cui received Ph.D. in Chemistry from Beijing Normal University (2011). Then, he was appointed as Lecturer, and later as Associate Professor (2014) at the College of Chemistry, Beijing Normal University. He has published more than 60 research papers in peer-reviewed journals and his research program has been fully funded by multiple grants from National Natural Science Foundation of China and other foundations. His fields of interest are the design, synthesis and bio-evaluation of molecular imaging probes (radiolabelled tracers for PET and SPECT; fluorophores for near-infrared imaging) for the diagnosis of diseases.
Dr. Kasi Pandima Devi is currently working as Associate Professor in Department of Biotechnology, Alagappa University, Karaikudi, India where she is engaged in teaching Master Degree students of Biotechnology Programme and also carrying out active research in the field of Molecular Pharmacology of Natural Products. She obtained her PhD degree in Biochemistry from University of Madras, India and subsequently did her Post-Doctoral research in National Institute of Immunology, India and CID-CSIC, Barcelona, Spain. She is a recipient of Young Women Scientist Award from the Government of Tamil Nadu, India and Women Scientist Award from the Biotech Research Society of India. She has published many research articles in reputed Journals and also co-authored many book chapters.
Roberto Di Santo is Full Professor of Medicinal Chemistry, School Pharmacy and Medicine, “Sapienza” University of Rome Italy. He holds Masters Degrees in Chemistry and Pharmacy from “Sapienza” University of Rome. Prof. Di Santo’s research is focused primarily on drug design and synthesis of new molecular entities endowed with biological activities. He devoted particular efforts in the discovery of antimicrobial and antitumor agents. Most part of scientific activity is focused on compounds active against HIV targets like integrase, ribonuclease H and polymerase functions of the reverse transcriptase, and protease. He is the author and co-author of books and over 130 publications and patents. Prof. Di Santo is an active member of EFMC and SCI.
Dr. Domínguez-Álvarez graduated from the University of Navarra (Spain) with MChem, MSci in Biochemistry and PhD in Medicinal Chemistry, with a PhD stay at the Saarland University (Germany). Later he did two postdocs at the Jagiellonian University Medical College (Poland); and at the Kazan Federal University (Russia). He joined as a CSIC Tenured Scientist at the Institute of General Organic Chemistry of the Spanish National Research Council (IQOG-CSIC) in Madrid, Spain; where he leads the Group of Medicinal Chemistry of Sulfur and Selenium Compounds, focusing on the synthesis of novel anticancer and antimicrobial sulfur- and selenocompounds.
Dr. Vera Lucia Eifler-Lima is currently Associate Professor in Faculty of Pharmacy at UFRGS and Head of the Dept. of Produção de Matéria-Prima, FAR 1, Faculdade de Farmácia/UFRGS. Her research involves the design, synthesis and pharmacological/toxicological evaluation of heterocyclic compounds aiming the identification of new antitumor (inhibitors of Eg5 kinesin, 5'NT) and antiparasitic (leishmania and chagas, mainly) hits. She is head of the CNPq Research Group “Medicinal Organic Synthesis” and Coordinator of the Laboratory of Medicinal Organic Synthesis (LaSOM).
Prof. André Ricardo Fajardo graduated in Chemistry (2007), M.Sc. (2009) and Ph.D. (2013) degrees in Chemistry from Maringá State University (Brazil). Ph.D from CERMAV Grenoble-France in 2013. Currently, he is a Professor at Universidade Federal Pelotas (Brazil) and research-leader in the Laboratory of Technology and Development of Composites and Polymeric Materials (LaCoPol). He is the author of approximate 50 papers with IF and his main research interests include polymer chemistry, polymeric biomaterials, polymeric composites, natural polymers, hydrogels, and absorbent materials.
Dr. Lian-Shun Feng obtained his PhD degree from Tsinghua University in 2011, and then worked as postdoctorial researcher in Peking University. Currently, Dr. Lian-Shun Feng work in WuXi AppTec as senior scientist, and supervise more than ten chemists. In 2017 and 2018, around 20 peer-reviewed SCI papers were published, and some of them were cited over 50 times in one year.
Dr. Luca Ferraro obtained a degree in Pharmacy from the University of Ferrara, Italy. He is a Professor of Pharmacology at the Dept. of Life Sciences and Biotechnology, University of Ferrara. He is currently affiliated with the Laboratory for Technologies of Advanced Therapies (LTTA – Tecnopolo), University of Ferrara as the Head of Service of "Animal models in drug testing." Since 2012, he is a member of the research team of the IRET Foundation (Ozzano Emilia, Bologna) for the study of neurodegenerative diseases. Dr. Ferraro is the author of about 150 publications in international journals in the field of Neuropharmacology and Neuroscience.
Prof. Matilde Yung Follo did PhD in human morphological and molecular sciences from the University of Bologna, Italy in 2007, MS in Medical Biotechnology, University of Bologna, Italy in 2003. He has been an Associate Professor in the Department of Human Anatomical Sciences (now Department of Biomedical and Neuromotor Sciences), at University of Bologna, Italy since 2014. He remained a Research Associate, in the same department as mentioned above from 2012 to 2014. He has been a Ph.D supervisor from 2014 to 2015, postdoctoral research fellowship supervisor from 2013 to 2014 and Master’s degree thesis supervisor from 2012 to 2013. He has been Associate Editor for Advances in Biological Regulation (since 2015), editorial board member of Mini-Reviews in Medicinal Chemistry (since 2015). He has attended a number of conferences and received scientific awards. He has 42 full length research papers to his credit.
Dr. Gentile (Naples, Italy) is a recognized expert in the transglutaminase research area and has a strong background in the molecular biology and biochemical aspects of the transglutaminase (TG) enzymes expression, activity and function. His work has been focused on the tissue TG (TG2) characterization in normal and pathological cellular events (cell growth and differentiation, adhesion, apoptosis, neurodegeneration) by molecular biology, immunological and biochemical studies. Currently, he works as associate professor at the University of Campania “Luigi Vanvitelli”.
Dr. Lia Ginaldi is a Full Professor of Applied Medical and Technical Sciences at the Department of Life, Health & Environmental Sciences of L’Aquila University. She is the Director of the Clinical Immunology and Allergology Unit of Teramo Hospital. She is Head of the Regional Center of Excellence on Osteoporosis and Clinical and Scientific Coordinator of the “Woman’s Health” and “Gender Medicine” Local Projects. Dr. Ginaldi is also the Coordinator of the Master of Gender Medicine and President of the Postgraduate Medical School for Specialists in Clinical Immunology and Allergology at the University of L’Aquila.
Dr Fedora Grande, after her honours graduation in Chemistry and Pharmaceutical Technology, from the University of Calabria, received her PhD degree “Metodologie per lo Sviluppo di Molecole di Interesse Farmacologico, XIX ciclo” in 2006. During the PhD course, and after, as Post Doc, she spent several secondments to the Department of Pharmaceutical Sciences, University of Southern California. The main goals of her research deal with the synthesis and the biological evaluation of small molecules endowed with pharmacological properties. More recently, she expanded her research interests on computer-based techniques toward the design of novel drugs. Since 2010, she is Assistant Professor in Pharmaceutical Chemistry, at the Department of Pharmacy, Health and Nutritional Sciences, University of Calabria.
Dr. Oliver Grundmann studied pharmacy at the Westfälische Wilhelms-Universität Münster and obtained his PhD in Pharmaceutical Sciences from the University of Florida. He also obtained a Master of Science in Forensic Toxicology from the same institution. Since 2014 he serves as an associate professor and director of two graduate programs in the College of Pharmacy at the University of Florida. His main research interest is natural products with central nervous system activity, drugs of misusage and abuse, and translational applications to study natural products and herbal supplements in clinical studies. He has authored over 60 peer-reviewed publications and 3 book chapters.
Dr. Shuang-Xi Gu received his Ph.D degree from Fudan University in 2012. He has worked in Wuhan Institute of Technology as a lecturer, associate professor and specially-appointed professor, successively. He conducted scientific research in University of Virginia as a postdoctoral fellow from 2014 to 2015 and a visiting scholar from 2017 to 2018. He has published more than 50 papers in scientific journals. He is serving as an editorial board member for Chinese Journal of Pharmaceuticals and Journal of Wuhan Institute of Technology, as well as a young editorial board member for Chinese Chemical Letters.
He is currently Professor in the Department of Pharmaceutical Chemistry, Sri Sai College of Pharmacy and Director-Research & Development, Sri Sai Group of Institutes, Badhani, Pathankot, India. He has obtained Ph.D. in the field of Pharmaceutical Sciences at Maharishi Markandeshwar (Deemed to be University) Mullana, India. He is also a member of many pharmaceutical associations and scientific societies. He is also an editorial board member, editor, guest editor and reviewer of many reputed international and national journals. From scientometry perspective, he has authored more than 100 ISI indexed documents with over 1000 citations and h-Index 19.
Dr Habtemariam received his BSc degree in Biology (minor - Chemistry) from the University of Addis Ababa and his Master’s degree (combined-studies) in Pharmacology and Phytochemistry from the University of Strathclyde, Glasgow, UK. He stayed at Strathclyde to study at doctoral level, studying on drug discovery researches and obtained his PhD in this area of research. After a number of years in teaching and post-doctoral research at the Strathclyde Institute for Drug Research and Strathclyde University, he joined the School of Science, University of Greenwich in September 1998. With a Principal Lecturer post at Greenwich, Dr Habtemariam has been a leader of programmes and researches taught on bioassays & natural products-based drug development. He has published more than 150 scientific publications and own 3 patents.
Andreas Hilgeroth studied pharmacy in Düsseldorf, Germany, and received his PhD degree with Professor Uwe Kuckländer, in 1994. He has been a research group leader and has developed novel antiretroviral drugs, potential Alzheimer’s therapeutics, multikinase inhibitors and antibacterial agents. His research projects have been supported by several grants from the German Research Foundation (DFG) and the European Union (EU) in various action programs, e.g. COST and Marie Curie support. His research results have been documented in more than 80 publications in international journals with partly high impact factors like Angewandte Chemie – International Edition in 2015.
Prof. Sabrin Ragab Mohamed Ibrahim graduated from Assiut University, Assiut, Egypt with good grades in Faculty of Pharmacy (1996). She worked as an assistant teacher at the Department of Pharmacognosy, Faculty of Pharmacy, Assiut University (1996-2000), during this time she received a master degree in pharmaceutical sciences, pharmacognosy. From 2000-2002, she worked as an associate lecturer at Faculty of Pharmacy, Assiut University. She worked as a Ph.D. student at Pharmazeutische Biologie Institute der Universität Heinrich- Heine, Düsseldorf, Germany from 2002 till 2005 and also completed her Ph.D. degree under supervision of Prof. Peter Proksch. She worked as an assistant professor (2005-2010) and associate professor (2010-2016) at the Department of Pharmacognosy, Faculty of Pharmacy, Assiut University. Currently, she works as professor at the Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, KSA and Department of Pharmacognosy, Faculty of Pharmacy, Assiut University.
Prof. Dr. Jamshed Iqbal (Tamgha-i-Imtiaz), FRSC is the Head of Pakistan’s finest drug research center CADR at COMSATS University, Abbottabad Campus since 2013. He has completed his early education from Pakistan, while he obtained his MS and PhD degrees from University of Strathclyde, Glasgow, UK and University of Bonn, Germany, respectively. After doing 2 Postdocs from Germany and China, he opted to serve Pakistan and joined the Department of Pharmacy, CUI, Abbottabad Campus. He has innovatory contributions in Pharmaceutical/Chemical sciences. Prof. Iqbal has more than 190 publications (Impact factor >550) in several top international journals and 2 international patents. In 2017, Prof. Iqbal has been awarded PAS-Gold Medal by Pakistan Academy of Sciences.
Dr. Ankit Jain acquired B. Pharm, M. Pharm. and Ph.D. degree from Dept. Pharm. Sci., Dr. Harisingh Gour Central University, Sagar (M.P.), India. He is a recipient of valuable national and international awards. He has published more than 60 international publications with high citation index including book chapters in reputed journals to his credit. Currently, he is DBT-Postdoctoral Research Associate, AMR Biomaterial's Lab, Department of Materials Engineering, Indian Institute of Science, Bangalore-560012 (Karnataka), INDIA. His research areas of interest include drug delivery, cancer-targeting, formulation by design, liposomes, polymeric and lipid-based nanofabrications, bioconjugation and theranostic exploration.
Dr. Vikas Jaitak obtained his Ph.D. degree in Natural Product Chemistry from Institute of Himalayan Bioresource Technology, CSIR, Palampur (HP), India in 2011. He is currently working as Assistant Professor at Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda (Pb), India. He is a recipient of various research awards like Young Scientist Award from Department of Science and Technology, India. His skills and expertise mainly lie in the subject area of Natural Products and Medicinal Chemistry. Dr. Jaitak, as an author/co-author and has published more than 55 articles in various journals (having over 950 total citations).
Dr. Jiang obtained his Ph.D. degree from the Shanghai Institute of Organic Chemistry, CAS and he subsequently pursued postdoctoral studies at the National Cancer Institute in the National Institutes of Health (NIH). In 2008 he joined the Guangzhou Institute of Biomedicine and Health, CAS as a principal investigator in the Laboratory of Medicinal Chemistry. In 2017, Professor Jiang moved his research group to the China Pharmaceutical University. His scientific interest is mainly focused on development of novel small drug-like molecules and peptidomimetic derivatives acting on targets of epigenetics and immuno-oncology. He has authored more than 70 papers in refereed scientific journals, including J. Med. Chem and Angew. Chem. Int. Ed.
Dr. Md Asaduzzaman Khan is currently working at the Research Center for Preclinical Medicine of Southwest Medical University as an Investigator/ Scientific Professor. He completed his bachelor's and Master's in Biochemistry and Molecular Biology from Jahangirnagar University, Bangladesh and received his doctoral degree in Biochemistry and Molecular Biology from the Central South University of China. Dr. Khan then had postdoctoral training at Luzhou Medical College under Zhejiang University and the University of Macao before he joined to a present position at Southwest Medical University. He is a member of the American Association for Cancer Research. His major research focuses on the molecular biology of cancer.
Prof. Dr. Haroon Khan has obtained the degree of B. Pharm (1999), M. Phil (2005), and PhD (2011) from the Department of Pharmacy, University of Peshawar. He started his career as a lecturer from the Gandhara College of Pharmacy, Gandhara University, Peshawar and currently he is Professor of Pharmacy at the Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan. He has almost 8 to 9 years of experience in pharmacy teaching, research and professional expertise in various fields of pharmaceutical sciences. Dr. Khan has 258 publications, including research, review, and editorial in various national and international reputable journals with considerable impact factor, while several others are submitted or in the process of submission. His research focus is phytomedicines including phytopharmacological and phytochemical investigations of extracts/isolated compounds in collaboration with numerous national and international research groups. He is also holding various editorial positions including Consulting Editor, Associate Editor, Regional Editor and Section Editor of various international journals. Prof. Khan has already edited a book with Elsevier publisher and written numerous book chapters for different international publishers. Additionally, he is supervising many post- graduate scholars in various research projects.
Imtiaz Khan received his Ph.D degree under the supervision of Prof. Hon Wai Lam, from The University of Nottingham, United Kingdom, where he developed new synthetic methodologies involving C‒H functionalization of inert bonds for the synthesis of carbo- and heterocycles. Later, he worked as a postdoctoral research associate in the same group for one year. He then spent two years (2016-2018) as a Leverhulme Trust research fellow at Cardiff University, before joining The University of Manchester, United Kingdom in 2018. He has a good contribution towards the scientific and academic community with numerous research publications in highly prestigious international journals. He is also an editorial board member of EC Pharmacology and Toxicology, United Kingdom.
Prof. Kamil Kuca has published more than 350 IF research papers. He is working with several companies as a scientific consultant. He has various collaborations throughout the world (e.g. Korea, Croatia, United Arab Emirates, USA, France, Turkey, China, Singapore, Sweden, and Brazil). His h-index is 39, and the number of citations in WoS is over 4000. He has five patents to his credit. In 2015, he was awarded the 7th most cited European author (2005- 2011) in pharmacology and toxicology, according to the list published by Lab Times.
Dr. Badireenath Konkimalla, Reader-F, National Institute of Science Education and Research (NISER), Bhubaneswar, India, has a Bachelor’s degree in Pharmacy from the Tamil Nadu Dr. M.G.R. Medical University, Chennai, India; an M. Tech. in Biotechnology from the Center for Biotechnology (CBT), Anna University, Chennai, India; and a Ph.D. in Biochemistry and Structural Biology from University of Heidelberg, Heidelberg, Germany. His research interests are in the interdisciplinary areas of pharmaceutical biology and drug development. He has been awarded the Mike Price fellowship award in the year 2009 by the European Association for Cancer Research (EACR), and Innovative Young Biotechnologist Award (IYBA) in the year 2012 by Department of Biotechnology (DBT), India.
Ioannis K. Kostakis is an assistant professor at National and Kapodistrian University of Athens, Greece. He graduated from the National and Kapodistrian University of Athens, School of Pharmacy with BSc, MSc and PhD (Medicinal Chemistry) and then undertook a postdoctoral fellowship in Medicinal Chemistry (Groupe de Chimie Pharmaceutique, Universite΄ de Rouen, France, 2007) and specialized to the use of microwaves in the synthesis of new compounds. His major areas of research interest relate to the design and synthesis of novel compounds with pharmaceutical interest.
Dr Vinod Kumar is an Associate Professor of Chemistry at the Central University of Haryana, India. He obtained his PhD degree in Chemistry in the year 2006 from Kurukshetra University, India. Dr Kumar has more than 12 years of experience in teaching and research. He has made significant contribution in the field of heterocyclic chemistry particularly Azoles’ chemistry covering pyrazole, isoxazole, thiazole, imidazole and triazole nuclei. He has contributed more than 75 publications in various journals of international repute and filed 6 patents. He co-authored a book on Pericyclic Reactions published by Academic Press, London and co-edited a book on Chemical Drug Design published by De Gruyter, Berlin, Germany. Furthermore, Dr Kumar is also serving in more than 40 international Journals of Royal Society, Elsevier, Hindawi, Springer, Bentham, Taylor & Francis publishers as Editorial Member or Reviewer or Guest Editor.
Dr. Enza Lacivita obtained her PhD in Medicinal Chemistry in 2001 from the University of Bari Aldo Moro. She was appointed as Assistant Professor in Medicinal Chemistry (2005) and as an Associate Professor in Medicinal Chemistry in 2017 (Department of Pharmacy – Drug Science) at the same University. Her research activities have been focused on the study of structure-activity relationships of “drug-like” ligands for GPCRs involved in neuropsychiatric disorders, such as serotonin and dopamine receptors, and in neuroinflammatory processes. Dr. Lacivita is a co-author of more than 70 papers in peer-reviewed journals and co-inventor of four patent applications.
Dr. Oleg Larionov obtained his doctoral degree from Georg-August University in Göttingen, Germany. After postdoctoral work at Max-Plank Institut für Kohlenforschung and Harvard University he began his independent career at the University of Texas at San Antonio, where he is now an Associate Professor of Chemistry. His research interests span medicinal chemistry, total synthesis of natural products, organic photochemistry, heterocyclic chemistry, and catalysis.
Dr. Lauria’s scientific is a lecturer of medicinal chemistry at the University of Palermo. In the first years, he worked on synthesis of heterocyclic compounds with antiproliferative activity. After his experience in USA, where he worked in the research group of Prof A.R. Katritzky, his interests were driven to molecular modelling. He is co- author of 93 papers published on ISI recognized international journals, with H-index 26. He has been involved in several research projects and has actively participated in the elaboration of several of them. He is an expert evaluator for HORIZON2020.
Marcello Leopoldo obtained the degree in Chemistry and Pharmaceutical Technologies (honors) at the University of Bari in 1991. At the same University, he was appointed as Research Associate in Medicinal Chemistry (1992) and then as Associate Professor (2001). He has received the Habilitation as Full Professor in 2015. He has published 115 papers focused on the development of selective ligands for dopamine, serotonin and formyl peptide receptors. Various selective 5-HT7 receptor agonists have been identified in his lab, including LP-211 which has been extensively used to explore the therapeutic potential of 5-HT7 receptor activation. He is an inventor of eight patent applications.
Dr. Dahong Li obtained his doctor degree (Ph.D.) in Medicinal Chemistry from China Pharmaceutical University (2013), China. After that, he became a faculty in the School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University. Dr. Dahong's research interests focus on medicinal chemistry and natural product chemistry. He has published more than 100 papers and applied for more than 50 patents.
He received his B.Eng. Degree, M.Eng. and Ph.D. degrees in computer science from Northeast Normal University, Changchun, China in 2009, 2012, 2015, respectively. Currently, he is an associate professor at the Department of Computer science and information technology, Northeast Normal University. He has published more than 70 research papers. His research interests include evolutionary computation, constrained optimization, bioinformatics, computational biology, and interdisciplinary research.
Dr. Giuseppe Losurdo graduated in Medicine in the year 2013. Currently, he is working in specialty school of Gastroenterology, University of Bari. He is an active member of Young team of the Italian society of Gastroenterology. Dr. Losurdo’s main fields of interest are Helicobacter pylori infection, celiac disease and inflammatory bowel disease.
Laura De Luca is an Associate Professor of Medicinal Chemistry at the University of Messina. Her main research interests are directed to drug design through molecular modeling approach of new molecules active into the fields of antiviral agents as RT and IN HIV inhibitors, carbonic anydrase inhibitors, tyrosinase inhibitors. Her scientific production consists of 101 papers, all published in international journals, more than 100 communications presented at international congresses and a chapter published in Burger's Medicinal Chemistry "Drug discovery and development", 7th ed.- Wiley (2010).
Dr. Lv is currently an associate professor in Nanjing University. He obtained his Ph.D. in Medicinal Chemistry at Nanjing University. He was a postdoctoral research associate in both College of Pharmacy and Department of Chemistry at Purdue University, West Lafayette, Indiana. His research activities have been focused on rational design, synthesis and biological evaluation of small molecules as potential anticancer, antibacterial or anti-inflammatory agents. Dr. Lv has published more than 70 papers in peer-reviewed journals and is an inventor of 14 patents.
Fawzi holds a life sciences degree and is a Harvard University Alumni with a deep rooted interest in biopharmaceutical and biomedical sciences. He has served as the Head of Department and presently is an associate professor at the University of Mauritius and a visiting professor in China. He is a recipient of more than 52 fellowships/travel grants/ and invited as plenary/keynote/invited speaker to present in international conferences. Fawzi is the scientific editor/reviewer/book proposal and grant evaluator and PhD examiner of more than100 peer- reviewed international scientific journals, books, and international grant reviewer (more than 15 - for MRC-UK, Poland, Germany, UNESCO, South Africa, and Netherlands). Fawzi is ranked as the top most prolific author from University of Mauritius and has authored more than 365 scientific publications with cumulative impact factor for his publications over 400.
Sarel Malan obtained a Ph.D. in Pharmaceutical Chemistry, M.Sc. and B.Pharm. from the North-West University, Potchefstroom, South Africa. He is Professor and Director of the School of Pharmacy at the University of the Western Cape and is an Honorary Life Member of the Academy of Pharmaceutical Sciences and Fellow of the Pharmaceutical Society of South Africa. He has published more than 75 scientific papers and has authored or co-authored various papers and columns in professional journals, and conference contributions.
Dr. Alejandro Romero is Associate Professor in the Department of Pharmacology and Toxicology at the Faculty of Veterinary Medicine of the Complutense University of Madrid (Madrid, Spain). Currently, he combines his interest and background on molecular toxicology in three well-stablished research lines; i) Evaluate and understand the molecular mechanisms of new molecules with therapeutic interest; ii) Identify the molecular mechanisms underlying the cell death pathways involved in the toxicity of xenobiotics; iii) Focus on novel melatonin-based therapies. Dr. Romero has 15 research projects, 100 national and international meetings and symposia, he has written 12 book chapters and he has published 79 research papers in peer-reviewed journals.
Dr. Masarik obtained a doctorate (Ph.D.) in Molecular Biology from the Masaryk University, Brno, Czech Republic. Currently, Dr. Michal Masarik is an assistant professor at the Department of Pathological Physiology, Faculty of Medicine, Masaryk University in Brno and senior scientist in Research group of Submicron Systems and Nanodevices in Central European Institute of Technology, Brno University of Technology. His research is mainly focused on prostate and head and neck cancer development, analysis of tumor biomarkers and effect of selected cytostatic drugs on tumor cell lines. He has published more than 100 scientific publications with h-index 22 and 1201 citations according WoS.
Dr Antonino Mazzaglia obtained a doctorate (Ph.D.) in Chemistry at the University of Catania, Italy. He got a Post-Doc Position at UCD, Ireland. Currently, Dr Mazzaglia is CNR Senior Researcher at ISMN (Dept ChiBioFarAm, University of Messina, Italy). He taught Chemistry at UNIME and obtained the qualification at Full Professor in Basic and Inorganic Chemistry. He was a Visiting Professor at the University of Exeter, lecturer in PhD Schools in Italy and Europe. He is a Member of Dottorato School in Chemical Science (UNIME), Italian and European Conferences Boards on Cyclodextrins (CD), Italian Society of Photobiology and Chairman of ICS2021 (International Cyclodextrin Symposium 2021). He is author of about 92 papers in ISI ( H- Index 27, about 1950 citations by Scopus).
Dr. P.V. Mohanan works as Scientist-G & Head in the Toxicology Division, Biomedical Technology Wing, at the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Govt. of India. He is a visiting professor at Toyo University, Japan and a visiting researcher at Bio-Nano Electronics Research Centre, Japan. Dr. Mohanan has a post-doctoral experience from the University of Tsukuba, Japan and Doctoral degree from the University of Kerala. As a toxicologist at SCTIMST with more than 30 years of experience, he has been intimately associated with all the medical devices technologies developed at SCTIMST. He has authored 175 peer reviewed full papers, 4 book chapters, edited 3 books and 4 conference proceedings.
Dr. Adriano Mollica is an Associate Professor of Medicinal Chemistry at the Univ. “G. d’ Annunzio” of Chieti-Pescara, Italy and PhD in “Pharmaceutical Sciences”. From 2013, he is a member of the Board of PhD program “Biomol. and Pharm. Sciences” and Tutor of several PhD students and post-doctoral fellows. His research interests are focused on opioid peptides, neurodegeneration, treatment of chronic and neuropathic pain, multi-target compounds and nutraceuticals. He is a co-author of 82 papers published in international journals, one European Patent and one Italian Patent. He is currently the “Editor in Chief” of “Current Bioactive Compounds”, and an Editorial Board Member of Mini-Reviews in Organic Chemistry and of Protein & Peptide Letters.
Dr. N.S. Hari Narayana Moorthy is a Professor in Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak. He has completed his Postdoctorate from the University of Porto and his postgraduate and doctorate degrees from Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal in pharmacy discipline. His primary research area is drug discovery and development. He has more than 18 years of teaching and research experiences. He has published 125 research and review articles in peer reviewed journals and has presented 101 articles in conferences. He has authored 4 book chapters in Bentham and other publishers. He has received Career Award for Young Teachers from AICTE, New Delhi for the year 2006 and Postdoctorate fellowship from Foundation of Science and Technology, Portugal.
Dr. Naveen Mulakayala obtained his Ph.D. from Sri Krishnadevaraya University in 2007 under the guidance of Prof. G.Narayana Swamy in the Department of Chemistry. He joined as a research associate in DR Reddy’s Institute of Life Sciences, Hyderabad, India. He was promoted as a research scientist in the same institute after 2 years. He also worked as a Principal scientist in Clearsynth Labs Ltd and joined SVAK Life Sciences as Head-Techno Commercial. Dr. Naveen’s research activity focuses on organic synthesis and methodologies employing environmentally benign homogeneous catalysts, API, API impurities and medicinal chemistry. He has authored more than 60 publications.
Seyed Mohammad Nabavi is a biotechnologist and senior scientist of Applied Biotechnology Research Center, Baqiyatallah University of Medical Science and a member of Iran's National Elites Foundation. His research focuses on the molecular pharmacology of natural products. He is authoror co-author of 250 publications in international journals, 51 communications at national and international congress, and six chapters in book series. Seyed Mohammad Nabavi is amongst the group of Highly Cited Researchers by Clarivate Analytics, 2018.
Kunal Nepali is an Assistant Professor in the School of Pharmacy, Taipei Medical University, Taiwan. He has expertise spanning medicinal chemistry and organic synthesis with ten years of experience in a broad range of drug discovery projects. He is the author of good number of research/review articles and is an ad-hoc reviewer of various reputed journals in the field of biomedical sciences. He has also received various recognitions/awards as a reviewer for Medicinal Research Reviews, European Journal of Medicinal Chemistry, Bioorganic chemistry, Bioorganic and Medicinal Chemistry Letter and others.
Orazio Nicolotti graduated in Chemistry and Pharmaceutical Technology and honors in 1997 and received the Ph.D. in Drug Sciences in 2001. His major expertise is in molecular and data modelling: drug design, QSAR, predictive toxicology, combinatorial library design, evolutionary algorithms, docking and molecular dynamics. So far, he has authored more than 100 research papers, 3 book chapters, and 1 international patent. He is a principal investigator of several research funded projects and industrial agreements for technology transfer.
With 37 years of teaching and research experience, Professor Nisheeth Desai was working as Professor & Head in the Department of Chemistry at Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, India and published more than 131 research papers in national and international journals. At present, he is working as BRS faculty fellow, University Grants Commission, New Delhi in the same Department. His research group has developed expertise in the synthesis of smart hybrid heterocyclic molecules with eco-friendly novel methodologies for the development of antimicrobial agents. The cumulative impact factor of his publications is more than 190, with 2252 citations, H index 27 and i10 index is 72. He has successfully guided 44 Ph.D students. His experience spans to be a reviewer for internationally reputed journals with high impact factors. He has 2 Indian patents to his credit and having undertaken research projects for all the funding agencies in India. He is a recipient of prestigious "Carrier Award for Young Scientist" from the University Grants Commission, New Delhi.
Dr. Liang Ouyang obtained his Ph.D in medicinal chemistry from West China School of Pharmacy, Sichuan University in 2008 and 2010, respectively. He is working as a full professor in Sichuan University. His research area involves the discovery of novel anticancer and neurodegenerative diseases. So far he has published more than 84 SCI academic peer reviewed papers, his articles have been cited more than 1700 times, the single highest number of citations is 607, and his H index is 20.
Margot Paulino Zunini received a degree in Pharmaceutical Chemistry and a Ph.D. in Chemistry from the Universidad de la República (UdelaR) Montevideo, in 1983 and 1993, respectively. She completed her postdoctoral studies in the Uppsala University and in the ETH Zurich. She has more than twenty years of experience in Structural Bioinformatics and Medicinal Chemistry research. At present, she is a professor of the Faculty of Chemistry (UdelaR) and of the Programa de Desarrollo de Ciencias Básicas (PEDECIBA). She is the Head of the Structural Bioinformatics Center mainly devoted to the study of the physicochemical properties of biomolecules and to the design of new bioactive compounds by means of in silico procedures.
Dr. Jiangnan Peng is an Assistant Professor of Chemistry at Morgan State University. He has specialized in new drug discovery from natural products. His research focuses on the identification and analysis of bioactive components from natural resources. He is author of over 80 papers in peer-reviewed journals, 2 book chapters, 2 patents, and numerous conference abstracts.
Dr. Pittalà attained her MSc in Chemical and Pharmaceutical Technologies, and subsequently completed her Ph.D. in Pharmaceutical Sciences at the University of Catania. Then, Dr. Pittalà moved to Milan to join Pharmacia Corporation as a research scientist. She worked as member of Combinatorial Chemistry Group and contributed to the discovery and identification of danusertib as co-inventor of bicyclopyrazoles chemicals. She currently holds the position of Assistant Professor at the University of Catania. Her major area of interest are the design and synthesis of heme oxygenase-1 inhibitors, and s receptor ligands as new antitumor agents. She has 7 patents to her credit
Miroslav Pohanka graduated in chemistry from Masaryk University Brno (Czech Republic) in 2003. He achieved doctor of natural science (RNDr) in biochemistry (2006) and PhD in biochemistry (2008) from Masaryk University. After that, he became associated professor (docent) of toxicology at the University of Defense, Czech Republic (2012). He achieved doctor of sciences in analytical chemistry from the Academy of Sciences, Czech Republic (2014) and became professor of analytical chemistry at University of Pardubice (2016). He is an author of approximately 200 papers in journals with IF and his work has been cited more than 1900 times according web of science.
Dr. Azhar Rasul is an Assistant Professor at Government College University Faisalabad. He obtained PhD fellowship jointly awarded by MoE, Pakistan and CSC, China and completed his Ph.D. in Chemical Cancer Biology from Northeast Normal University, China. He later received China postdoctoral fellowship in 2012, Japanese Society for Promotion of Science (JSPS) Postdoctoral fellowship in 2013, and subsequently Tokyo Biochemical Research Foundation (TBRF) fellowship in 2015. He has published over 100 peer-reviewed articles with cumulative impact factor over 208 and with over 1670 citations. He has presented several invited talks at National and International level. He has obtained several national and international research grants. His lab is actively engaged in interdisciplinary research on novel tumor biomarkers and identification of non-toxic anti-cancer compounds for various hallmarks of cancer from natural sources. He is reviewer and editorial board member of several well-reputed journals.
Dr. Eleni Rekka is a professor in Medicinal Chemistry, School of Pharmacy, Aristotelian, University of Thessaloniki, Greece. She did B.Sc. in Pharmacy in 1977 and Ph.D. in Medicinal Chemistry in 1986 from School of Pharmacy, Aristotle, University of Thessaloniki. She has worked for more than three years in Universities and Research Institutes of Europe, as research associate. Dr. Rekka has 102 publications, more than 100 presentations at international and national congresses, two patents and was the coordinator of three funded projects. Her fields of expertise are Drug design and synthesis, mechanism of action structure/activity relationships, Free radicals, oxidative stress and antioxidant agents and xenobiotic metabolism.
Dr. Rodriguez obtained a doctorate (Ph.D.) in Chemistry from the Universidad de Buenos Aires (1990). Then, he became a Postdoctoral Fellow at the National Institutes of Health (1992-1993). He was appointed as Assistant Professor (1997), and then Professor (2005) both at the Department of Organic Chemistry, Universidad de Buenos Aires. He has published more than 70 scientific publications and is a named inventor of 5 U.S. patents. His fields of interest are the design of antiparasitic and antiviral agents as well as total synthesis of compounds of pharmacological importance.
Prof. Blazej Rubis is Head of the Department of Clinical Chemistry and Molecular Diagnostics at Poznan University of Medical Sciences, Poland. Prof. Rubis graduated in the year 2000 with majors in Biotechnology from the University of Natural Sciences, Poznan, Poland. He spent 2 years (2014-2016) for postdoctoral studies in the Department of Pathology and Laboratory Medicine at Brown University, Providence, RI, USA. His skills and expertise mainly lie in the subject areas of Molecular Biology, Cancer Research, Genetics, Cell Biology, Evolutionary Biology, and Structural Biology. Dr. Rubis, as an author/co-author, has published more than 50 articles in various journals, having over 475 total citations.
Dr. Ji Hyun Ryu is currently working at the Wonkwang University as an assistant professor. He received his doctoral degree in nanoscience and technology from Korea Advanced Institute of Science and Technology. Then, he had postdoctoral training at the University of California San Diego and Duke University School of Medicine. His research is focused on the biomaterials for various medical applications including wound healing, tissue adhesives, and hemostasis during surgical procedures as well as for drug delivery and tissue engineering.
Mina Saeedi received her Ph.D. degree in Organic Chemistry in 2011 from Alzahra University under the direction of Professor Majid M. Heravi. The main focus of her Ph.D. research was synthesis of novel heterocyclic compounds. During a sabbatical leave, she joined Professor Lars Engman at Uppsala University, Sweden and worked on the synthesis of chalcogenide antioxidants. Then, she joined the group of Professor Abbas Shafiee at Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences (TUMS) as a postdoctoral fellow. Currently she is an Assistant Professor at TUMS, Persian Medicine and Pharmacy Research Center as well as Medicinal Plants Research Center at the Faculty of pharmacy. Her research has focused on the isolation and identification of organic compounds obtained from natural sources as well as design and synthesis of potentially bioactive compounds especially possessing anti-Alzheimer’s activity.
Prof. Marcus Tullius Scotti obtained his Ph.D. degree (2008) in Organic Chemistry from University of São Paulo, Brazil. In January 2009, Prof. Scotti moved to João Pessoa and started to work as Professor of Organic Chemistry at Universidade Federal da Paraíba (Federal University of Paraíba), Brazil. He is currently working in the same university, and his skills and expertise mainly lie in the subject areas of Chromatography, Medicinal and Pharmaceutical Chemistry, Antioxidant Activity, Natural Product Chemistry, Density Functional Theory, Computational Chemistry, Phytochemicals, Drug Discovery, etc. Prof. Scotti, as an author/co-author, has published more than 145 articles in various journals, having over 1,125 total citations.
Professor Yuk Sham received his PhD from the University of Southern California Chemistry Department and his post-doctoral trainings at the US National Cancer Institute and IBM TJ Watson Research Center. He joined University of Minnesota in 2002 as the scientific consultant specializes in biomolecular modeling, simulation and computer-aided drug design. He serves as the assistant professor and assistant director at the University of Minnesota Center for Drug Design from 2008-2016. He is currently the assistant professor at the University of Minnesota Department of Integrative Biology and Physiology and the director of graduate studies for the Bioinformatics and Computational Biology program.
Dr. Singh received the B. Pharmacy (2003) and M. Pharmacy (2005) from Panjab University, Chandigarh and Ph.D. (2013) from PTU, Jalandhar. He has over 15 years of teaching experience and guided various PGs and PhDs. He has to his credit over 60 papers in SCI and SCOPUS indexed journals, 50 Conference proceedings, 2 Books, 6 Best Paper Awards and 05 projects from different government agencies. He is currently an EBM of 08 International Journals and Reviewer of over 20 scientific journals. He has received Publon Award 2016, 2017 and Publon “Excellent Peer Reviewer award” for outstanding reviewing more than 120 research papers.
Eduardo Marcelo Sobarzo Sanchez is a Full Professor and Researcher at the Instituto de Investigación e Innovación en Salud (I3S), Universidad Central de Chile (CHILE). He was a professor and researcher at the University of Chile (CHILE) and University of Santiago de Compostela (USC, SPAIN), wherein he followed as an associate researcher at the Faculty of Pharmacy (USC) in the field of Natural Products- Medicinal Chemistry against CNS diseases, experimental studies about drug delivery systems and parasitology. From these research lines, there have been generated more than 100 scientific articles of high impact factor in the field of Chemistry, Pharmacy and Nanotechnology compiled in several journals.
Prof. Sabrina Taliani did Master Degree summa cum laude in Chemistry and Pharmaceutical Technologies, from the University of Pisa in 1994, PhD degree in Medicinal Chemistry from the same university in 1998. She gained a permanent position “Tecnico Laureato” (graduated technician) in the Department of Pharmaceutical Science, University of Pisa. She served as assistant professor of Medicinal Chemistry at the University of Pisa during 2001-2015. Since 2015, she is serving as associate professor of Medicinal Chemistry in the Department of Pharmacy, University of Pisa. Her research interests are in various medicinal chemistry fields, such as Central Benzodiazepine Receptor (BzR) ligands. She developed new classes of high affinity ligands, including the indolylglyoxylamides, 3-aryltriazinobenzimidazoles and 2-phenyltriazolobenzotriazines and Adenosine Receptor (AR) modulators. Prof. Taliani described several classes of novel A1, A2A, A2B and A3 selective antagonists featuring non-purine heterocyclic structures, and a series of 1-benzyl-3-ketoindoles as the first class of A2B AR selective allosteric modulators. She studied new classes of high affinity and selectivity ligands, the 2-phenylindolglyoxylamides, and 4-phenylquinazolinecarboxamides, for both therapeutic and diagnostic applications. Prof. Taliani developed inhibitors targeting different enzymes such as aldose reductase, adenosine deaminase, metalloproteinases, carbonic anhydrases, tyrosine kinases and antitumoral agents. She also studied novel small molecules as apoptosis inducers or neuroprotective agents. All the above researches are carried out in collaborations with Italian and international teams. She is a member of the Italian Society of Chemistry. She has to her credit more than 110 papers on high-impact international journals and 1 patent.
Dr. Salam Titinchi is an Associate Professor at the Department of Chemistry, University of the Western Cape, Cape Town, South Africa. He obtained his PhD from Indian Institute of Technology Roorkee. He has published more than 60 scientific articles and conference proceedings in the field of catalysis, medicinal chemistry and nanomaterial and edited a book and authored two book chapters on drug delivery and catalysis. He serves on the editorial boards of an international scientific journal. His research interests lie in the field of design and synthesis of new potential anticancer compounds, coordination polymers and advanced nanomaterial for environmental applications and green chemistry.
Dr. Seyithan TAYSI received his PhD in Medical Biochemistry from Medical School University of Ataturk, Erzurum, Turkey. While doing his Ph.D., his best article as a young scientist received the jury's special award. He received many awards related to his publications and conducted his postdoctoral training in the Department of Medical Biochemistry at the University of Gaziantep, Turkey. He still works as a professor at the same university. He served as editorial board member and reviewer board in different journals, and authored over 100 publications.
Marianna Török is an Assistant Professor of Chemistry at the University of Massachusetts Boston. After receiving her M.S. in Chemistry from University of Szeged, Faculty of Science (formerly known as József Attila University, Faculty of Science), she completed Ph.D. in Biological Sciences (Biochemistry) at the University of Szeged, Faculty of Medicine (formerly known as Albert Szent-Györgyi Medical University, Faculty of Medicine), Hungary. She did postdoctoral training in Structural Biology with Ralf Langen at the University of Southern California, Los Angeles, CA and in Peptide Chemistry with Daniel S. Kemp at the Massachusetts Institute of Technology, Cambridge, MA. Her current research interest includes Physical Biochemistry, Medicinal Chemistry, and Green Chemistry.
Claudio Viegas Jr. is currently an Associate Professor at the Federal University of Alfenas . In 1999, he turned to Araraquara (São Paulo State, Brazil) to develop his PhD Thesis on Natural Products and Medicinal Chemistry. Since 2016, he is the coordinator of the Program of Post-Graduation in Chemistry of the Federal University of Alfenas. Scientific Coordinator of the Laboratory of Research in Medicinal Chemistry (PeQuiM), his research is focused on the design, synthesis and evaluation of innovative drug candidates for neurodegenerative diseases, CNS disorders, neglected diseases, neurophatic and central pain and inflammation. Dr. Viegas-Jr. has published over 60 peer-reviewed manuscripts and review articles in these areas and is funded by multiple operating grants from the Brazilian Agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG).
Frank Wuest is a Professor in the Department of Oncology at the University of Alberta in Canada. He obtained his training in chemistry and biochemistry from Dresden Technical University in Germany. He performed postdoctoral research studies at the School of Medicine in St. Louis from 1999-2001, and he worked as head of the PET-Tracer Department of the Research Centre Dresden-Rossendorf in Germany from 2001-2008. In 2008 he was appointed as the Dianne and Irving Kipnes Chair in Radiopharmaceutical Sciences at the University of Alberta.
Dr. Hui Xu is a professor at Research Institute of Pesticidal Design & Synthesis, Northwest A&F University. He obtained his Ph.D. degree from Zhejiang University. He then became the director of a Medicinal Research Group at Jiangsu Yangtze River Pharmaceutical Group, Jiangsu Province, China. In 2004, he joined the group of Professor Bruno Figadere, Faculty of Pharmacy, University of Paris-Sud 11 as a postdoctoral fellow. Since 2008, he has held the position of full professor at Northwest A&F University. So far, he has published over 80 peer-reviewed SCI articles. His main research interests are on the activity-guided isolation, structural modification and structure−activity relationships of bioactive natural products.
Dr. Andrey A. Zamyatnin Jr. is currently a Professor and Head of the Institute of Molecular Medicine at Sechenov First Moscow State Medical University, Moscow, Russia. He earned his Ph.D. in Virology and later D.Sc. in Virology and Molecular Biology from Lomonosov Moscow State University, Moscow, Russia. His current research interests include molecular markers, molecular targets, development of immunotherapy and enzymatic therapy approaches. Additionally, his research interests include programmed cell death, RNAi, and virus-host interactions. Dr. Zamyatnin’s scientific publications include more than 50 articles in peer-reviewed journals. Furthermore, he acts as an Expert in several scientific funds.
Dr. Khurshid Ahmad is an Assistant Professor at the Department of Medical Biotechnology, Yeungnam University, Republic of Korea. His research mainly focuses on skeletal muscle and extracellular matrix biology, by employing state-of-the-art in silico, molecular biology, and cell culture techniques. He has over 60 papers published in reputed international journals, three book chapters, and over 15 abstracts presented at international and national scientific conferences. He also serves as a reviewer for over 30 high-impact journals.
Dr. Mohammad Arshad, received his B.Sc (Hons) Chemistry, M.Sc. Chemistry from Aligarh Muslim University, India and Doctor of Philosophy (Ph.D.) on the thesis entitled “Novel heterocyclic compounds as potential therapeutic agents: Synthesis and The characterization” from Medicinal Chemistry Research Laboratory, CIRBSc, JMI, New Delhi, India. He has more than five years of postdoctoral experience of teaching as well as research and published more than thirty research articles in valued journals. He is serving as an advisory board member, reviewer and active member of many scientific societies. Currently, he is working at Shaqra University, Kingdom of Saudi Arabia, where he is dealing with the design, synthesis, characterization, biological, and molecular docking studies.
Dr. Atul Bhargava completed his M.Sc from H.N.B. Garhwal University, India and Ph.D from National Botanical Research Institute, Lucknow, India. He also served as Research Associate at the Laboratory of Cellular and Molecular Cytogenetics, University of Delhi. In 2007, he joined Amity Institute of Biotechnology, Lucknow as Assistant Professor (Biotechnology). Currently, Dr. Atul Bhargava holds the position of Associate Professor and Head, Dept of Botany at Mahatma Gandhi Central University, Motihari, Bihar, India. He has over 19 years of research experience in work on medicinal plants, especially the underutilized crops. He has about 48 research papers in reputed journals, 4 books (SpringerNature, CRC, CABI, Nova Publ.) and numerous book chapters to his credit. Dr. Bhargava is also serving as an editorial board member of several international journals of repute.
Dr. Mirjana B. Čolović, a research associate has been employed at the University of Belgrade, Serbia, since 2005. Her research activities are in the field of enzymology, toxicology, biosensors, physiologically active compounds and their interaction with biomolecules. She has published 36 papers in impact factor international journals, 4 chapters in books, 3 articles in national scientific journals, and over 60 abstracts in international and national scientific meetings. She served as a reviewer in over 20 international journals and 9 projects.
Dr. Sandipan Chakraborty completed his B.Sc. in Chemistry from University of Calcutta, India, and his M.Sc. in Bioinformatics from West Bengal University of Technology, India. Later on, he obtained his Ph.D. in Biophysics, Molecular Biology and Bioinformatics from University of Calcutta. Dr. Chakraborty is actively involved in teaching and doing research in drug discovery, atomistic simulation, spectoscopy and protein chemistry. He worked as an Assistant Professor in Chemistry at Saroj Mohan Institute of Technology, India, and is currently working as Research Associate at Indian Association for the Cultivation of Science, India. Dr. Chakraborty has published over 50 research articles in peer-reviewed international journals, and 3 book chapters.
Dr. Hamid Emadi, Assistant professor, has been employed at University of Mazandaran, Babolsar, I. R. Iran, from 2018. His research activities are in the field of synthesis of magnetic nanostructures and their applications as MRI contrast agents, drug delivery systems, and hyperthermia. He has published 20 papers in impacted international journals and 7 articles in international and national scientific meetings. He served as a reviewer in 11 international journals and 7 projects.
Assoc. Prof., Dr. Tomasz M. Karpiński is the Head of the Department of Medical Microbiology, Poznań University of Medical Sciences (PUMS), Poland. He received DDS from PUMS and MSc in Biology from Adam Mickiewicz University in Poznań. He also completed Postgraduate Studies: Laboratory Medicine at the PUMS, and Internet and mobile technologies at the Poznań University of Technology. He has Specialization in Medical microbiology. He obtained a PhD and DSc (habilitation) in microbiology from PUMS. He is an Expert of the National Centre for Research and Development. He is an editorial board member and a guest editor of some journals and a reviewer for more than 30 journals. He has about 80 publications in the field of medical microbiology, pharmacology and medical chemistry. His research interests are in the areas of human microbiome, bacterial pathogenesis, DNA viruses, biologically active agents of bacterial origin, antibacterial and anticancer substances/drugs, and carcinogenesis.
Joanna Izabela Lachowicz received her MSc in biotechnology from University of Wroclaw in 2006, where she performed graduate research with Prof. Henryk Kozlowski. In 2010, Joanna Izabela obtained a PhD in chemistry from University of Cagliari, where she worked with Prof. Valeria M. Nurchi. In 2012, she started her work at the University of Cagliari as PhD. In 2017, Italian National Habilitation Commission, gave her the title of Associated Professor. She focuses on synthetic small organic molecules as metal chelating agents and metal-complex equilibria in water. Moreover, she is studying metal complex formation with peptides, as well as with known drugs in use.
Dr. Qianbin Li is a professor at the Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University. He received a BS degree in pharmacy in 2003 and a PhD in medicinal chemistry in 2008 from Shandong University. He joined the School of Pharmacy, Virginia Commonwealth University, as a postdoctoral fellow in February 2008. His current research projects focus on the development of innovative drugs of fibrosis-related disease, cancer, cardiovascular diseases and metabolic disease. Key areas of concentration within the group comprise chemical biology based target identification and validation, virtual screening, structure-based drug design or optimization, organic synthesis, molecular level mechanism of action and druggability study on potential candidates.
Dr. Zhengchun Liu received his Ph.D. degree in Biomedical Engineering from Southeast University, Nanjing, China, in 2003. From 2004 to 2006, he was a postdoctoral fellow at Seoul National University, Seoul, South Korea. From 2014 to 2015, he was a visiting scholar at the University of Maryland, College Park, MD, USA. Dr. Liu joined Central South University as an Associate Professor in 2007, and has been Full Professor since 2010. Furthermore, he is Associate Editor for the International Journal of Nanoscience and Nanotechnology Letters. His major research interests focus on nanocarriers and nanosensors.
Dr. Arindam Maity is an Associate Professor in the School of Pharmaceutical Technology, Adamas University, Kolkata. He has more than 8 years of teaching experience in various Pharmacy colleges and 5.5 years of research experience during his Ph.D. and Post-Doctoral research. He has specialized in Medicinal Chemistry, Natural Product Chemistry, Synthetic Bioorganic Chemistry (DNA, LNA & click chemistry; fluorescently labeled nucleosides & oligonucleotides); & DNA/RNA oligonucleotides in molecular diagnostic. During his research work, he has published 43 international publications & 4 book chapters. He is also associated as a reviewer with a number of journals, also acts as an Editorial board member, Advisory Board Member of few Journals. He also presented as an Invited speaker in a number of National and International Journals.
Dr. Mbianda obtained his PhD in Chemistry from the University of Montpellier, France. Then he worked as postdoctoral fellow and research Associate in the department of Chemistry and Chemical Pathology at the University of Pretoria, South Africa, respectively. Currently, he is an Associate Professor in the Department of Applied Chemistry at the University of Johannesburg, South Africa. His research interest involved the synthesis of organic polymers, nanomaterials and their application in drug delivery systems. He has published over 50 research articles in peer-reviewed Journals, and 3 book chapters. He served as reviewer and/or guest editor in more than 15 international journals.
Dr. Bilal Ahmad Mir is an Assistant Professor & Coordinator at the Department of Botany University of Kashmir. He obtained PhD in Botany CSIR-Indian Institute of Integrative Medicine, Jammu, J&K INDIA & Guru Nanak Dev University, Amritsar, INDIA. He has been awarded INSA Visiting Scientist Fellowship for the year 2017-2018, Early Career Research Award by SERB, DST, GOI, New Delhi, Dr. D.S. Kothari Postdoctoral Fellowship, University Grants Commission (UGC), New Delhi, INDIA and he was also Invited as young PI for YIM 2018 held at Thiruvananthapuram, Kerala (5-8 March 2018). He is an editorial board member of different journals such as Applied Biology and Biotechnology, Biologically Active Products from Nature (Taylor and Francis Group), Advances in Bio-medicine and Pharmacy and Journal of Herbal Medicine, Beijing.
Dr. Niladri Mukherjee, completed his doctoral research in March 2017 from Department of Zoology, Visva-Bharati, India, studying different molecular and biochemical aspects of filarial parasitology. He completed his tenure of two years as a National Post-Doctoral Fellow at CSIR-Indian Institute of Chemical Biology, India and currently working as Guest Faculty at the Department of Animal Science, Kazi Nazrul University, India. His current research objective is to evaluate the mechanistic insights of anti-leishmanial activity of some novel compounds and some repurposed drugs with emphasize on host cell survival and macrophage polarization through modulation of PI3K/Akt pathway, ceramide signaling, and lipid body accumulation. To date, he has published 26 research papers in peer-reviewed international journals.
Dr Pradeep Nareddy is a native of India. After securing a First Class Bachelor’s Degree with distinction in Organic Chemistry at Osmania University, he moved to IIT Bombay for a Master's Degree. He subsequently moved to the University of Geneva in Switzerland and worked on the asymmetric catalysis and their applications in the lab of Prof. Clement Mazet to obtain a PhD degree. He then moved to Germany for Postdoctoral studies with Prof. Christoph Schneider at Leipzig University. To broaden his interests, he moved to the USA for second Postdoctoral studies with Prof. Szostak and Prof Jordan in sustainable catalysis. He started as a postdoc at Moffitt Cancer Center in 2018, and as of 2020, he is a Research Scientist at Moffitt Cancer Center in the Chemical Biology core.
Dr. Milan M. Obradovic is a senior research associate in the Department of Radiobiology and Molecular Genetics at the Institute of Nuclear Sciences “Vinca”, University of Belgrade, Serbia. He received a PhD in molecular biology and endocrinology from the University of Belgrade, Serbia. He has experience in basic and clinical science research. His investigative interest is to clarify the role of different hormones in normal cardiovascular biology and in pathophysiological conditions such as obesity, insulin resistance, diabetes, metabolic syndrome and cardiovascular diseases. He serves as a member of editorial board and as a reviewer in numerous scientific and medical journals.
Dr. Shaoyong Ke is an Associate Professor in the National Biopesticide Engineering Research Center (NBERC). His research interests include the application of target-oriented and diversity-oriented syntheses of small molecules for drug discovery, and natural products-oriented discovery of novel active molecules as lead compounds for development of agrochemicals or drug. He has published more than 50 peer-reviewed journal articles/book chapters in the field of medicinal chemistry and pesticidal chemistry. Dr. Ke has served the scientific community as an editorial board member for three journals and as a reviewer for more than 25 journals.
Dr. Seong-Lin Teoh is a senior lecturer in the Department of Anatomy, of Universiti Kebangsaan Malaysia. He is the coordinator of the Master of Medical Sciences (Anatomy), and the deputy secretary of the Malaysian Anatomical Association. His work has been focused to the characterization of different herbs in diabetic cutaneous wound healing; and neuroregeneration and neurodegeneration using zebrafish animal model.
Lei Zhao is an M.D & Ph.D., postdoc of Harvard Medical School, Professor and Chief Physician of Infectious Diseases in the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. He is the head of the multidisciplinary collaboration platform for infection and inflammation in Wuhan Union Hospital. He participated in national major special projects, the National Natural Science Foundation of China, the Natural Science Foundation of Hubei Province, and published 39 papers in the SCI journals as the first author or correspondening author, and participated in 2 monographs.
Dr. S. Kabilan is presently serving as a Professor and Dean at the Department of Chemistry, Annamalai University in India. He completed his M.Sc in 1982 and Ph.D. in 1989 in Chemistry Annamalai University, India. His research interest includes the Synthesis of biological active Organic compounds and reaction dynamics. Dr. Kabilan is currently working on Designing active molecules using Schrodinger software, followed by synthesizing the active molecules. He completed CSIR-2, DBT, DBT(NEC), ICMR and UGC projects. He has contributed his valuable publications in different scientific journals.
Jian-Qiang Liu received Ph.D from Northwest University. He completed his postdoc at Tsinghua University (with Prof. Lin Mei, 2015-2016) and has been working as a full professor at Guangdong Medical University. His research interests include multifunctional metal-organic framework nanomaterials, and stimuli-responsive (bio) polymers. He has published more than 50 papers. H-index = 22. He has been appointed as an editorial board member of several journals, such as: Interdisciplinary Journal of Chemistry; and EC Pharmacology and Toxicology etc.
Eduardo Marcelo Sobarzo Sanchez is a Full Professor and Researcher at the Instituto de Investigación e Innovación en Salud (I3S), Universidad Central de Chile (CHILE). He was a professor and researcher at the University of Chile (CHILE) and University of Santiago de Compostela (USC, SPAIN), wherein he followed as an associate researcher at the Faculty of Pharmacy (USC) in the field of Natural Products- Medicinal Chemistry against CNS diseases, experimental studies about drug delivery systems and parasitology. From these research lines, there have been generated more than 100 scientific articles of high impact factor in the field of Chemistry, Pharmacy and Nanotechnology compiled in several journals.
Dr. Salam Titinchi is an Associate Professor at the Department of Chemistry, University of the Western Cape, Cape Town, South Africa. He obtained his PhD from Indian Institute of Technology Roorkee. He has published more than 60 scientific articles and conference proceedings in the field of catalysis, medicinal chemistry and nanomaterial and edited a book and authored two book chapters on drug delivery and catalysis. He serves on the editorial boards of an international scientific journal. His research interests lie in the field of design and synthesis of new potential anticancer compounds, coordination polymers and advanced nanomaterial for environmental applications and green chemistry.
Alla P. Toropova (PhD) has been working in Istituto di Ricerche Farmacologiche Mario Negri Milano, Italy. She had published of about 240 papers in international journals on QSPR/QSAR analysis for inorganic and organometallic compounds, in particular, thermodynamic properties of coordination compounds of bioactive metals, and thermodynamic properties (e.g. solubility) of nano substances. She has been working since over 20 years in the fields of Chemoinformatics and Nanoinformatics. She also has made scientific collaborations with many experts in the fields of Chemoinformatics and Nanoinformatics throughout the world.
Dr. Wang is now an Associate Professor at Jiangsu Institute of Parasitic Diseases. He is an expert in the field of infectious diseases and tropical diseases. His research interest involved emerging and reemerging infectious diseases, neglected tropical diseases, and drug resistance. Currently, Dr. Wang is a co-Editor-in-Chief of World Journal of Clinical Infectious Diseases, Managing Editor of Zoonoses and Chinese Journal of Schistosomiasis Control, and is on the editorial board of Infectious Diseases of Poverty, Journal of Tropical Medicine, BMC Public Health, BMC Infectious Diseases, BioMed Research International, World Journal of Clinical Cases, Current Drug Therapy, Global Health Journal, Infectious Disorders - Drug Targets, et al. Dr. Wang has published more than 150 papers in the international and national peer-reviewed journals, including The New England Journal of Medicine, The Lancet Infectious Diseases, Journal of Travel Medicine, Stem Cell Research & Therapy, and The Journal of Infectious Diseases.
